Folic acid supplementation dysregulates gene expression in lymphoblastoid cells - Implications in nutrition

Biochemical and Biophysical Research Communications

Volumn 412, Issue 4, 2011, Pages 688-692

  Junaid, Mohammed A ^a   Kuizon, Salomon ^a   Cardona, Juan ^a   Azher, Tayaba ^a   Murakami, Noriko ^a   Pullarkat, Raju K ^a   Brown, W Ted ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

DNA methylation; Epigenetics; Folic acid; Fragile X mental retardation; Gene expression; Neural tube defects

Indexed keywords

FOLIC ACID; FRAGILE X MENTAL RETARDATION PROTEIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 37L1; MESSENGER RNA; PROTEIN SERINE KINASE; TESTIS SPECIFIC SERINE KINASE 3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

CELL LINE; DIET; DIETARY SUPPLEMENTS; DNA METHYLATION; FOLIC ACID; GENE EXPRESSION; GENOMIC IMPRINTING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 80052614248     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.027     Document Type: Article

References (42)

1. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Mortal. Wkly. Rep. 1992, 41:1-7. MMWR.
2. Honein M.A., Paulozzi L.J., Mathews T.J., et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001, 285:2981-2986.
3. Folic acid for the prevention of neural tube defects: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 2009, 150:626-632. U.S. Preventive Services Task Force.
4. Pitkin R.M. Folate and neural tube defects. Am. J. Clin. Nutr. 2007, 85(suppl.):285S-288S.
5. De Wals P., Tairou F., Van Allen M.I., et al. Reduction in neural-tube defects after folic acid fortification in Canada. New Engl. J. Med. 2007, 357:135-142.
6. Folate. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline 1998, Institute of Medicine, National Academies Press, Washington, DC, pp. 196-305.
7. Wald N.J., Law M.R., Morris J.K., et al. Quantifying the effect of folic acid. Lancet 2001, 358:2069-2073.
8. Jaszewski R., Misra S., Tobi M., et al. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J. Gastroenterol. 2008, 4:4492-4498.
9. Clarke R., Halsey J., Lewington S., et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch. Intern. Med. 2010, 170:1622-1631.
10. Ford A.H., Flicker L., Alfonso H., et al. Vitamins B12, B6, and folic acid for cognition in older men. Neurology 2010, 75:1540-1547.
11. Rosado J.L., Gonzalez K.E., Caamano M.D., et al. Efficacy of different strategies to treat anemia in children: a randomized clinical trial. Nutr. J. 2010, 9:40.
12. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 2000, 71:121-138.
13. Lister R., Pelizzola M., Dowen R.H., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
14. Waterland R.A., Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 2003, 23:5293-5300.
15. Gray J.D., Ross M.E. Mechanistic insights into folate supplementation from crooked tail and other NTD-prone mutant mice. Birth Defects Res. A Clin. Mol. Teratol. 2009, 85:314-321.
16. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8:253-262.
17. Gregg C., Zhang J., Weissbourd W., et al. High-resolution analysis of parent-of-origin allelic expression in the mouse brain. Science 2010, 329:643-648.
18. Badcock C., Crespi B. Battle of the sexes may set the brain. Nature 2008, 454:1054-1055.
19. Smith D.A., Kim Y.-I., Refsum H. Is folic acid good for everyone?. Am. J. Clin. Nutr. 2008, 87:517-533.
20. Steegers-Theunissen R.P., Obermann-Borst S.A., Kremer D., et al. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 2009, 4:e7845.
21. Whitrow M.J., Moore V.M., Rumbold A.R., et al. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am. J. Epidemiol. 2009, 170:1486-1493.
22. S.E. Haberg, S.J. London, H. Stigum, et al., Folic acid supplements in pregnancy and early childhood respiratory health, Arch. Dis. Child. 94 (2009) 180-184. Erratum in: Arch. Dis. Child. 94 (2009) 485.
23. Achon M., Reyes L., Alonso-Aperte E., et al. High dietary folate supplementation affects gestational development and dietary protein utilization in rats. J. Nutr. 1999, 129:1204-1208.
24. Rampersaud G.C., Kauwell G.P.A., Hutson A.D., et al. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 2000, 72:998-1003.
25. Junaid M.A., Sklower-Brooks S., Wisniewski K.E., et al. A novel assay for lysosomal pepstatin-insensitive proteinase and its application for the diagnosis of late-infantile neuronal ceroid lipofuscinosis. Clin. Chim. Acta 1999, 281:169-176.
26. M. Barua, E.C. Jenkins, W. Chen, et al., Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity - implications for autism, Autism Res. (2011) [Epub ahead of print]. doi:10.1002/aur.197.
27. Kuizon S., DiMaiuta K., Walus M., et al. A critical tryptophan and Ca2+ in activation and catalysis of TPPI, the enzyme deficient in classic late-infantile neuronal ceroid lipofuscinosis. PLoS ONE 2010, 5:e11929.
28. Bucko-Justyna M., Lipinski L., Burgering B.M., et al. Characterization of testis-specific serine-threonine kinase 3 and its activation by phosphoinositide-dependent kinase-1-dependent signaling. FEBS J. 2005, 272:6310-6323.
29. Herranz M., Esteller M. DNA methylation and histone modifications in patients with cancer: Potential prognostic and therapeutic targets. Methods Mol. Biol. 2007, 361:25-62.
30. Lechner M., Boshoff C., Beck S. Cancer epigenome. Adv. Genet. 2010, 70:247-276.
31. Pfeiffer C.M., Fazili Z., McCoy L., et al. Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologic assay. Clin. Chem. 2004, 50:423-432.
32. Hannisdal R., Ueland P.M., Svardal A. Liquid chromatography-tandem mass spectrometry analysis of folate and folate catabolites in human serum. Clin. Chem. 2009, 55:1147-1154.
33. K.M. Laurence, N. James, M.H. Miller, et al., Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects, Br. Med. J. (Clin. Res. Ed.) 282 (1981) 1509-1511.
34. Heseker H.B., Mason J.B., Selhub J., et al. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br. J. Nutr. 2009, 102:173-180.
35. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27:370-377.
36. Valdenaire O., Giller T., Breu V., et al. A new family of orphan G protein-coupled receptors predominantly expressed in the brain. FEBS Lett. 1998, 424:193-196.
37. Zuercher G., Rohrbach V., Andres A.C., et al. A novel member of the testis specific serine kinase family, tssk-3, expressed in the Leydig cells of sexually mature mice. Mech. Dev. 2000, 93:175-177.
38. Visconti P.E., Hao Z., Purdon M.A., et al. Cloning and chromosomal localization of a gene encoding a novel serine/threonine kinase belonging to the subfamily of testis-specific kinases. Genomics 2001, 77:163-170.
39. Greenman C., Stephens P., Smith R., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
40. Badcock C., Crespi B. Imbalanced genomic imprinting in brain development: an evolutionary basis for the aetiology of autism. J. Evol. Biol. 2006, 19:1007-1032.
41. Tsankova N., Renthal W., Kumar A., et al. Epigenetic regulation in psychiatric disorders. Nat. Rev. 2007, 8:355-367.
42. Tamura Y., Kunugi H., Ohashi J., et al. Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol. Psychiatr. 2007, 12:593-600.